- Home
- FRGE vs ENTA Comparison
FRGE vs ENTA Comparison
Compare FRGE & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRGE
- ENTA
- Stock Information
- Founded
- FRGE 2014
- ENTA 1995
- Country
- FRGE United States
- ENTA United States
- Employees
- FRGE N/A
- ENTA N/A
- Industry
- FRGE Computer Software: Prepackaged Software
- ENTA Biotechnology: Pharmaceutical Preparations
- Sector
- FRGE Technology
- ENTA Health Care
- Exchange
- FRGE Nasdaq
- ENTA Nasdaq
- Market Cap
- FRGE 354.6M
- ENTA 316.2M
- IPO Year
- FRGE N/A
- ENTA 2013
- Fundamental
- Price
- FRGE $44.09
- ENTA $12.25
- Analyst Decision
- FRGE Hold
- ENTA Strong Buy
- Analyst Count
- FRGE 5
- ENTA 6
- Target Price
- FRGE $38.25
- ENTA $20.33
- AVG Volume (30 Days)
- FRGE 890.7K
- ENTA 408.7K
- Earning Date
- FRGE 11-13-2025
- ENTA 11-17-2025
- Dividend Yield
- FRGE N/A
- ENTA N/A
- EPS Growth
- FRGE N/A
- ENTA N/A
- EPS
- FRGE N/A
- ENTA N/A
- Revenue
- FRGE $92,884,000.00
- ENTA $65,324,000.00
- Revenue This Year
- FRGE $32.73
- ENTA $2.13
- Revenue Next Year
- FRGE $21.74
- ENTA $2.74
- P/E Ratio
- FRGE N/A
- ENTA N/A
- Revenue Growth
- FRGE 16.40
- ENTA N/A
- 52 Week Low
- FRGE $6.60
- ENTA $4.09
- 52 Week High
- FRGE $44.76
- ENTA $15.34
- Technical
- Relative Strength Index (RSI)
- FRGE 89.36
- ENTA 59.58
- Support Level
- FRGE $44.00
- ENTA $11.80
- Resistance Level
- FRGE $44.24
- ENTA $13.55
- Average True Range (ATR)
- FRGE 0.97
- ENTA 0.82
- MACD
- FRGE 0.85
- ENTA 0.09
- Stochastic Oscillator
- FRGE 97.15
- ENTA 57.36
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.
About ENTA Enanta Pharmaceuticals Inc.
Enanta Pharmaceuticals Inc is an American biotechnology company which uses robust, chemistry-driven approach and drug discovery capabilities to focus on the research and development of molecule drugs to cure viral infections and liver diseases. Uses virology and immunology method for curing the diseases. The targeted diseases are hepatitis C, hepatitis B, nonalcoholic steatohepatitis, and the respiratory syncytial virus. The novelty of company research is a specific direct-acting antiviral inhibitor against the hepatitis C virus. The company's inhibitors have been developed in collaboration with AbbVie. AbbVie markets the protease inhibitor, paritaprevir, while other inhibitors are in the pipeline.